PPIs Tip Sheet: CYP2C19 Poor Metabolizers
The following information is intended for use by providers who are attempting to prescribe certain PPIs (omeprazole, pantoprazole, lansoprazole, and dexlansoprazole) to Biobank participants with CYP2C19 poor metabolizer phenotypes.
If you have questions, please call the pharmacogenomics consult pager at (303) 266-4510.